HC Surgical Specialists Ltd
SGX:1B1

Watchlist Manager
HC Surgical Specialists Ltd Logo
HC Surgical Specialists Ltd
SGX:1B1
Watchlist
Price: 0.27 SGD -8.47% Market Closed
Market Cap: 41.5m SGD
Have any thoughts about
HC Surgical Specialists Ltd?
Write Note

Profitability Summary

73/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
HC Surgical Specialists Ltd

Revenue
18.8m SGD
Cost of Revenue
-2.8m SGD
Gross Profit
16m SGD
Operating Expenses
-9.8m SGD
Operating Income
6.2m SGD
Other Expenses
-2.4m SGD
Net Income
3.8m SGD

Margins Comparison
HC Surgical Specialists Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SG
HC Surgical Specialists Ltd
SGX:1B1
41.5m SGD
85%
33%
20%
US
Cigna Corp
NYSE:CI
89.4B USD
11%
4%
1%
US
Cigna Group
XMUN:CGN
82.6B EUR
11%
4%
1%
US
CVS Health Corp
NYSE:CVS
69.9B USD
14%
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR
25%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
19.1B EUR
23%
6%
-5%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.3B USD
28%
9%
3%
US
Quest Diagnostics Inc
NYSE:DGX
17.8B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
12.4B USD
33%
15%
7%
AU
Sonic Healthcare Ltd
ASX:SHL
13B AUD
84%
9%
6%
Country SG
Market Cap 41.5m SGD
Gross Margin
85%
Operating Margin
33%
Net Margin
20%
Country US
Market Cap 89.4B USD
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 82.6B EUR
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 69.9B USD
Gross Margin
14%
Operating Margin
3%
Net Margin
1%
Country DE
Market Cap 23.4B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 19.1B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-5%
Country US
Market Cap 20.3B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Country US
Market Cap 17.8B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 11.6B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 12.4B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
Country AU
Market Cap 13B AUD
Gross Margin
84%
Operating Margin
9%
Net Margin
6%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
HC Surgical Specialists Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SG
HC Surgical Specialists Ltd
SGX:1B1
41.5m SGD
29%
13%
33%
36%
US
Cigna Corp
NYSE:CI
89.4B USD
7%
2%
10%
7%
US
Cigna Group
XMUN:CGN
82.6B EUR
7%
2%
10%
7%
US
CVS Health Corp
NYSE:CVS
69.9B USD
7%
2%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
19.1B EUR
-6%
-2%
3%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
20.3B USD
5%
2%
8%
5%
US
Quest Diagnostics Inc
NYSE:DGX
17.8B USD
13%
6%
10%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR
4%
2%
5%
3%
US
DaVita Inc
NYSE:DVA
12.4B USD
104%
5%
13%
10%
AU
Sonic Healthcare Ltd
ASX:SHL
13B AUD
7%
4%
7%
5%
Country SG
Market Cap 41.5m SGD
ROE
29%
ROA
13%
ROCE
33%
ROIC
36%
Country US
Market Cap 89.4B USD
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 82.6B EUR
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 69.9B USD
ROE
7%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 23.4B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country DE
Market Cap 19.1B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Country US
Market Cap 20.3B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Country US
Market Cap 17.8B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
Country DE
Market Cap 11.6B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country US
Market Cap 12.4B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
10%
Country AU
Market Cap 13B AUD
ROE
7%
ROA
4%
ROCE
7%
ROIC
5%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top